Key Insights

Highlights

Success Rate

95% trial completion (above average)

Published Results

118 trials with published results (13%)

Research Maturity

596 completed trials (67% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.5%

31 terminated out of 883 trials

Success Rate

95.1%

+8.6% vs benchmark

Late-Stage Pipeline

14%

122 trials in Phase 3/4

Results Transparency

20%

118 of 596 completed with results

Key Signals

118 with results95% success31 terminated

Data Visualizations

Phase Distribution

631Total
Not Applicable (235)
Early P 1 (4)
P 1 (147)
P 2 (123)
P 3 (70)
P 4 (52)

Trial Status

Completed596
Unknown121
Recruiting65
Terminated31
Active Not Recruiting23
Not Yet Recruiting23

Trial Success Rate

95.1%

Benchmark: 86.5%

Based on 596 completed trials

Clinical Trials (883)

Showing 20 of 20 trials
NCT07170735RecruitingPrimary

Quantitative Measurement of Plasma and Urine MTB Cell-free DNA Level

NCT01212003Recruiting

Training Protocol on the Natural History of Tuberculosis

NCT05571735Recruiting

Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

NCT00115609Phase 3Completed

Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)

NCT06253715Phase 3RecruitingPrimary

Shortened Regimen for Drug-susceptible TB in Children

NCT04926922Active Not RecruitingPrimary

PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia

NCT04466488Not ApplicableCompleted

Prevent TB: Choice Architecture for TPT Delivery

NCT04930744Phase 2CompletedPrimary

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)

NCT06593080Not ApplicableRecruitingPrimary

The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis

NCT05586230Phase 1RecruitingPrimary

Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis

NCT07484490Not ApplicableRecruitingPrimary

Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in Tuberculosis

NCT07485868Not Yet RecruitingPrimary

Development of a Clinical-epidemiological Score Predictive of Tuberculosis.

NCT05917210Not ApplicableRecruitingPrimary

Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda

NCT05547464Phase 1Active Not RecruitingPrimary

Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers

NCT07479030Not ApplicableNot Yet RecruitingPrimary

A Home-Based Approach to Tuberculosis Preventive Treatment Management

NCT05947890Phase 2Recruiting

Evaluating the Safety and Immunogenicity of MTBVAC

NCT05989802Not ApplicableRecruitingPrimary

Rapid Research in Diagnostics Development for TB Network (R2D2 Kids) and Assessing Diagnostics At POC for TB in Children (ADAPT for Kids)

NCT05941052Not ApplicableRecruitingPrimary

Assessing Diagnostics At Point-of-care for Tuberculosis

NCT04230395Not ApplicableRecruitingPrimary

Alcohol Reduction Among People With TB and HIV in India

NCT07459569Not ApplicableNot Yet RecruitingPrimary

Diagnostic Performance and Safety of Endobronchial Ultrasound-guided Transbronchial Mediastinal Cryobiopsy in Diagnosing Tuberculous Mediastinal Lymphadenitis: a Randomised Controlled Trial

Scroll to load more

Research Network

Activity Timeline